After much delay, a WHO team of international experts went to Wuhan in January 2021 to look into the origins of the virus in cooperation with their Chinese counterparts.
The WHO experts noted that baricitinib, a type of drug known as a Janus kinase (JAK) inhibitor, has similar effects to other arthritis drugs called interleukin-6 (IL-6) inhibitors.